GL1X · GenesisL1 explorer

MolNFT v2 · #227448 · protein

Autoinhibited full-length LRRK2(I2020T) on microtubules with MLi-2

9CHO · Leucine-rich repeat serine/threonine-protein kinase 2: “Autoinhibited full-length LRRK2(I2020T) on microtubules with MLi-2”. Electron microscopy at 7.8, 2 ligands (GDP, A1N), 20 pockets (best druggability 0.82). MolNFT v2 #227448 on…

PDB
9CHO
Type
protein
Length
1,792 residues
Chains
1
Method
electron microscopy
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
7.8
Source
Homo sapiens
Molecule
Leucine-rich repeat serine/threonine-protein kinase 2
EC
2.7.11.1, 3.6.5.-
UniProt
Q5S007
Ligands
GDP, A1N
Pockets
20 · best druggability 0.82

Structure

electron microscopy · resolution 7.8 · 1 distinct chain · 29% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1, 3.6.5.-)protein179229% helix, 16% strandQ5S007

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • A1N · (2~{R},6~{S})-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1~{H}-indazol-3-yl]pyrimidin-4-yl]morpholine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 15 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17680.820.85100empty
210160.770.7959empty
311270.760.78107empty
42460.750.8939empty
52540.740.8846empty

Compared structures

  • Q5S007 · AlphaFold monomer V2.0 prediction for leucine-rich repeat SERINE/THREONINE-protein kinase… · a predicted model of the same protein · chain A against A, TM-score 0.61

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.